Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis

NCT00674700 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

509

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: 300 IR house dust mites allergen extract tablet
DRUG: 500 IR house dust mites allergen extract tablet
DRUG: Placebo tablet

Sponsor

Stallergenes Greer